U.S. federal trademark · Serial No. 85468743 · Reg. No. 4192203
Medical services, namely, treatment of neurological disorders and treatment of neuroinflammatory and neuropsychiatric disorders; treatment of Alzheimer's disease, dementia, stroke, sciatica and other forms of neuropathic pain utilizing cytokine antagonists including TNF inhibitors; treatment of chronic neurological dysfunction, namely, weakness, speech and language dysfunction, cognitive dysfunction, visual difficulties or sensory disturbance following stroke; treatment of brain glial activation and microscopic inflammation related to Alzheimer's disease; and treatment of neuropsychiatric conditions associated with neuroinflammation
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.